FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2953647285> ?p ?o ?g. }

• W2953647285 endingPage "e028578" @default.
• W2953647285 startingPage "e028578" @default.
• W2953647285 abstract "Introduction The POInT study, an investigator initiated, randomised, placebo-controlled, double-blind, multicentre primary prevention trial is conducted to determine whether daily administration of oral insulin, from age 4.0 months to 7.0 months until age 36.0 months to children with elevated genetic risk for type 1 diabetes, reduces the incidence of beta-cell autoantibodies and diabetes. Methods and analysis Infants aged 4.0 to 7.0 months from Germany, Poland, Belgium, UK and Sweden are eligible if they have a >10.0% expected risk for developing multiple beta-cell autoantibodies as determined by genetic risk score or family history and human leucocyte antigen genotype. Infants are randomised 1:1 to daily oral insulin (7.5 mg for 2 months, 22.5 mg for 2 months, 67.5 mg until age 36.0 months) or placebo, and followed for a maximum of 7 years. Treatment and follow-up is stopped if a child develops diabetes. The primary outcome is the development of persistent confirmed multiple beta-cell autoantibodies or diabetes. Other outcomes are: (1) Any persistent confirmed beta-cell autoantibody (glutamic acid decarboxylase (GADA), IA-2A, autoantibodies to insulin (IAA) and zinc transporter 8 or tetraspanin 7), or diabetes, (2) Persistent confirmed IAA, (3) Persistent confirmed GADA and (4) Abnormal glucose tolerance or diabetes. Ethics and dissemination The study is approved by the ethical committees of all participating clinical sites. The results will be disseminated through peer-reviewed journals and conference presentations and will be openly shared after completion of the trial. Trial registration number NCT03364868 ." @default.
• W2953647285 created "2019-07-12" @default.
• W2953647285 creator A5008742337 @default.
• W2953647285 creator A5021568045 @default.
• W2953647285 creator A5024413040 @default.
• W2953647285 creator A5026087442 @default.
• W2953647285 creator A5026837875 @default.
• W2953647285 creator A5028741505 @default.
• W2953647285 creator A5029030825 @default.
• W2953647285 creator A5030730584 @default.
• W2953647285 creator A5052837634 @default.
• W2953647285 creator A5054554375 @default.
• W2953647285 creator A5059916451 @default.
• W2953647285 creator A5071794983 @default.
• W2953647285 creator A5076896987 @default.
• W2953647285 creator A5086462994 @default.
• W2953647285 creator A5089471811 @default.
• W2953647285 creator A5089738768 @default.
• W2953647285 date "2019-06-01" @default.
• W2953647285 modified "2023-10-01" @default.
• W2953647285 title "Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol" @default.
• W2953647285 cites W1569803097 @default.
• W2953647285 cites W1913359344 @default.
• W2953647285 cites W1973364036 @default.
• W2953647285 cites W1974161959 @default.
• W2953647285 cites W1990514655 @default.
• W2953647285 cites W2013359164 @default.
• W2953647285 cites W2015941944 @default.
• W2953647285 cites W2030685032 @default.
• W2953647285 cites W2044423567 @default.
• W2953647285 cites W2047768051 @default.
• W2953647285 cites W2051883261 @default.
• W2953647285 cites W2059707463 @default.
• W2953647285 cites W2071456238 @default.
• W2953647285 cites W2086547450 @default.
• W2953647285 cites W2087704501 @default.
• W2953647285 cites W2090742005 @default.
• W2953647285 cites W2093623454 @default.
• W2953647285 cites W2095256598 @default.
• W2953647285 cites W2099424483 @default.
• W2953647285 cites W2111562530 @default.
• W2953647285 cites W2123412381 @default.
• W2953647285 cites W2130004850 @default.
• W2953647285 cites W2130136130 @default.
• W2953647285 cites W2133827756 @default.
• W2953647285 cites W2134391999 @default.
• W2953647285 cites W2147677306 @default.
• W2953647285 cites W2155063253 @default.
• W2953647285 cites W2171825365 @default.
• W2953647285 cites W2277933781 @default.
• W2953647285 cites W2407782134 @default.
• W2953647285 cites W2765403943 @default.
• W2953647285 cites W2769332703 @default.
• W2953647285 cites W2776280 @default.
• W2953647285 cites W2795575996 @default.
• W2953647285 cites W2894846947 @default.
• W2953647285 cites W4246356838 @default.
• W2953647285 cites W4254965081 @default.
• W2953647285 doi "https://doi.org/10.1136/bmjopen-2018-028578" @default.
• W2953647285 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6609035" @default.
• W2953647285 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31256036" @default.
• W2953647285 hasPublicationYear "2019" @default.
• W2953647285 type Work @default.
• W2953647285 sameAs 2953647285 @default.
• W2953647285 citedByCount "54" @default.
• W2953647285 countsByYear W29536472852019 @default.
• W2953647285 countsByYear W29536472852020 @default.
• W2953647285 countsByYear W29536472852021 @default.
• W2953647285 countsByYear W29536472852022 @default.
• W2953647285 countsByYear W29536472852023 @default.
• W2953647285 crossrefType "journal-article" @default.
• W2953647285 hasAuthorship W2953647285A5008742337 @default.
• W2953647285 hasAuthorship W2953647285A5021568045 @default.
• W2953647285 hasAuthorship W2953647285A5024413040 @default.
• W2953647285 hasAuthorship W2953647285A5026087442 @default.
• W2953647285 hasAuthorship W2953647285A5026837875 @default.
• W2953647285 hasAuthorship W2953647285A5028741505 @default.
• W2953647285 hasAuthorship W2953647285A5029030825 @default.
• W2953647285 hasAuthorship W2953647285A5030730584 @default.
• W2953647285 hasAuthorship W2953647285A5052837634 @default.
• W2953647285 hasAuthorship W2953647285A5054554375 @default.
• W2953647285 hasAuthorship W2953647285A5059916451 @default.
• W2953647285 hasAuthorship W2953647285A5071794983 @default.
• W2953647285 hasAuthorship W2953647285A5076896987 @default.
• W2953647285 hasAuthorship W2953647285A5086462994 @default.
• W2953647285 hasAuthorship W2953647285A5089471811 @default.
• W2953647285 hasAuthorship W2953647285A5089738768 @default.
• W2953647285 hasBestOaLocation W29536472851 @default.
• W2953647285 hasConcept C126322002 @default.
• W2953647285 hasConcept C134018914 @default.
• W2953647285 hasConcept C142724271 @default.
• W2953647285 hasConcept C159654299 @default.
• W2953647285 hasConcept C163764329 @default.
• W2953647285 hasConcept C187212893 @default.
• W2953647285 hasConcept C203014093 @default.
• W2953647285 hasConcept C203092338 @default.
• W2953647285 hasConcept C204787440 @default.
• W2953647285 hasConcept C27081682 @default.

• next